Ország: Egyesült Királyság
Nyelv: angol
Forrás: myHealthbox
Tamoxifen (as citrate)
Milpharm Limited
L02BA01
Tamoxifen (as citrate)
20mg
Tablets
Oral use
packs of 30 tablets
POM - Prescription Only Medicine
Milpharm Limited
treatment of breast cancer and of anovulatory infertility
Authorised
2007-08-29
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. ! Keep this leaflet. You may need to read it again. ! If you have any further questions, ask your doctor or pharmacist. ! This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. ! If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. IN THIS LEAFLET: 1. What Tamoxifen Tablets are and what are they used for 2. Before you take Tamoxifen Tablets 3. How to take Tamoxifen Tablets 4. Possible side effects 5. How to store Tamoxifen Tablets 6. Further information Tamoxifen belongs to a group of medicines called anti-oestrogens. It is used in the treatment of breast cancer as well as anovulatory infertility (infertility related to problems with release of eggs in the ovaries). DO NOT TAKE TAMOXIFEN TABLETS if you: ! have ever had an allergic (hypersensitive) reaction to tamoxifen or any of the other ingredients in the product _(see Section 6 What Tamoxifen _ _Tablets contain')_ ! are pregnant or breast-feeding ! have a history or family history of clotting or clotting tendencies. TAKE SPECIAL CARE WITH TAMOXIFEN TABLETS Speak to your doctor if you: ! become pregnant while taking the tablets ! do not get your periods ! have irregular periods, vaginal bleeding or unusual discharge, pain/pressure in the pelvic region ! notice development of any tumour in any part of your body ! believe you have venous thromboembolism (blood clot in a vein). TAKING OTHER MEDICINES Please inform your doctor if you are taking or have recently taken any other medicines, including those obtained without a prescription. In parti Olvassa el a teljes dokumentumot
Tamoxifen 20mg Tablets Summary of Product Characteristics Updated 28Aug2015 | Aurobindo Pharma Milpharm Ltd. 1. Name of the medicinal product Tamoxifen 20mg Tablets 2. Qualitative and quantitative composition Each tablet contains 20mg Tamoxifen (as citrate) For excipients, see 6.1 3. Pharmaceutical form Tablet White to offwhite, round, biconvex, tablets with scoring and '20' embossed on one side. 4. Clinical particulars 4.1 Therapeutic indications 1. The treatment of breast cancer 2. The treatment of anovulatory infertility 4.2 Posology and method of administration Route of administration: Oral 1. Breast cancer Adults The recommended daily dose of tamoxifen is normally 20 mg. No additional benefit, in terms of delayed recurrence or improved survival in patients, has been demonstrated with higher doses. Substantive evidence supporting the use of treatment with 3040 mg per day is not available, although these doses have been used in some patients with advanced disease. Elderly patients Similar dosing regimens of 'Tamoxifen' have been used in elderly patients with breast cancer and in some of these patients it has been used as sole therapy. 2. Anovulatory Infertility Before commencing any course of treatment, whether initial or subsequent, the possibility of pregnancy must be excluded. In women who are menstruating regularly, but with anovular cycles, the initial course of treatment consists of 20 mg given daily on the second, third, fourth and fifth days of the menstrual cycle. If unsatisfactory basal temperature records or poor preovulatory cervical mucus indicate that this initial course of treatment has been unsuccessful, further courses may be given during subsequent menstrual periods, increasing the dosage to 40 mg and then to 80 mg daily. In women who are not Olvassa el a teljes dokumentumot